Skip to main content
PRVAPrivia Health Group, Inc.Sell6.1·$20.77+0.24%

Privia Health Group (PRVA) Q2 2026 earnings — TrendMatrix coverage

MISS-22.2% vs estimateEPS $0.19 vs $0.24 estCurrent verdict Sell 6.1/10

Reported

Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results. How we score · Full disclosure

Event detail · Q2 2026

Key numbers

Reported EPS
$0.19
Estimate
$0.24
Surprise
-22.2%
Revenue (period 2026-06-30)
$632.6M
Score today
6.1/10

Revenue source: xbrl.

Report record · Q2 2026

How the report landed

Privia Health Group (PRVA) missed the $0.24 estimate with diluted EPS of $0.19 — a large 22.2% shortfall.

Current read · as of 2026-09-04

Where TrendMatrix's rating stands now

TrendMatrix currently rates PRVA Sell at 6.1/10; no pre/post engine snapshot brackets this report.

2 of the last 4 quarters beat the estimate; this quarter's -22.2% surprise compares with a +4.4% four-quarter average. Next scheduled report: 2026-11-05.

What argues against it

  • Quality below floor (3.9 < 4.0)
  • Value-trap signals (2/5): Material insider selling (42 sells, 0.29% of cap), Negative free cash flow

This section and the ones below it reflect TrendMatrix’s latest engine read — they update after the report date and are not frozen to it.

Current engine read

The levels TrendMatrix's engine tracks

Current price
$20.77
Price target
$28.50
Stop
$19.72
Upside to target
+37.2%
Reward-to-risk
7.6:1

The stock trades at 94.0× trailing but 19.4× forward earnings — consensus estimates already build in a substantial earnings recovery.

Risk check: RSI 20 — a level conventionally read as oversold; trading volume is running 2.0× its average — elevated turnover around the report window.

Model outputs from TrendMatrix’s engine as of 2026-09-04 — shown for context, not personalized investment advice.

Healthcare context

PRVA at TrendMatrix's latest read

Healthcare earnings trade on pipeline and payer dynamics as much as the quarter itself; a beat or miss is weighed against trial and reimbursement news.

Industry
Health Information Services
Market cap
$2.64B
P/E (fwd)
19.4
P/E (ttm)
94.0
52-week range
$19.53$28.82
Off 52-week high
27.9%
RSI (14)
20
Volume vs avg
2.01×
Score today
6.1/10

Earnings figures are sourced from TrendMatrix’s pipeline (EPS: existing earnings extraction; revenue: SEC XBRL company facts where available, yfinance-provisional otherwise). Not a buy/sell rating, a price target, or investment advice — see the current verdict on the stock’s main page for TrendMatrix’s live read.

Home Stocks PRVA Earnings Q2 2026 earnings